2022 annual financial data
Vistagen Therapeutics 2022 Financial results
Direct answer
Revenue was 1,108,900 USD.
Operating income was -47,778,900 USD and net income was -47,762,400 USD.
Operating cash flow was -45,256,500 USD.
Get free Vistagen Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,108,900 USD
- Operating income
- -47,778,900 USD
- Net income
- -47,762,400 USD
- Operating cash flow
- -45,256,500 USD
Explore related company data
View all 2022 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Vistagen Therapeutics financial years